Thought Leaders
Insights From ISPOR 2025: R In Health Technology Assessment – Is It The Future?
ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and research in HEOR and market access. In this series, our experts share...
Transforming Global Market Access: Smarter Resource Management with Local Affiliates – A Live Webinar
Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? Join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Wednesday 21st May, to discover how...
Live Q&A: Beyond NHS England – Navigating changes at NHSE and DHSC
What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care (DHSC)? What do these changes mean for your...
Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.
In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...
Uniphar Secures 10th Cell and Gene Therapy Project
[Dublin, April 17th 2025] Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s...
Petauri unites Mtech Access and Delta Hat under one team: Petauri Evidence
Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions.
Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program
Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...
Live Q&A: Beyond NHS England – Restructuring and its implications for Pharma and Medtech
What does the abolition of NHS England mean for your market access and NHS Engagement strategy? How will the changes at national and integrated care board (ICB) level impact launch...
Communicating value to US Payers: Insights for Pharma and Medtech
What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...
The abolition of NHS England: Navigating NHS restructuring and its impact on the pharmaceutical industry
Last week Prime Minister Sir Keir Starmer announced the abolition of NHS England to "cut bureaucracy" and bring management of the health service "back into democratic control". This significant change...
Navigating market access: Launch strategies and health economic modelling for medical devices – a live panel discussion
Discover how health economics can support successful Medical Device launch, proposition development, and market access. Join us live at 1:30pm (GMT) on Wednesday 19th March for an insightful journey into...
Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading
The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...